wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28485252-083971E1-5119-49E0-A163-4FB773BBD7A0
Q28485252-083971E1-5119-49E0-A163-4FB773BBD7A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28485252-083971E1-5119-49E0-A163-4FB773BBD7A0
Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo
P2860
Q28485252-083971E1-5119-49E0-A163-4FB773BBD7A0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28485252-083971E1-5119-49E0-A163-4FB773BBD7A0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae82e48c1c04213f6d674dbf97181b964e4c20d4
P2860
A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.